A

Amgen

Makes biotech medicines for serious illnesses

Process Development Scientist

Bioprocess & BiomanufacturingConfirmed live in the last 24 hours
Full-timeCambridge, MA, USAIn-person

About the Job

Requirements

  • A doctorate degree, or a master's degree and two years of scientific experience, or a bachelor's degree and four years of scientific experience.
  • A master's degree in Physics, Materials Science, Pharmaceutical Sciences, Chemical Engineering, Chemistry, Biochemistry, or a related scientific discipline is preferred.
  • Strong background in solid-state nuclear magnetic resonance spectroscopy method development and theory, with a record of scientific presentations such as peer-reviewed publications.
  • Experience in solid-state nuclear magnetic resonance instrumentation, operation, and maintenance is beneficial.
  • Experience developing solid-state nuclear magnetic resonance methods to characterize small- and large-molecule drug substances and drug products, including solid-form analysis, impurity-phase or amorphous-content detection, and physical-stability assessment.
  • Experience in solid-state characterization using techniques such as differential scanning calorimetry, thermogravimetric analysis, X-ray powder diffraction, microscopy, moisture sorption, and particle characterization is desired.
  • Working knowledge of solid-form development, including polymorphism, solvates, hydrates, and salt or co-crystal characterization, is beneficial.
  • Informatics skills and experience with molecular-modeling calculations to study molecular interactions and simulate nuclear magnetic resonance experimental observables are beneficial.
  • Ability to communicate and present key messages in writing and verbally to diverse audiences.
  • Ability to solve problems proactively and collaborate in cross-functional, multidisciplinary environments.
  • Ability to take initiative, work independently, and be flexible in responsibilities.

Responsibilities

  • Use advanced solid-state characterization methods, such as solid-state nuclear magnetic resonance spectroscopy, to support drug-substance and drug-product process development for synthetic and biologics programs.
  • Drive lead optimization and form selection to meet discovery research and process-development requirements, including the Target Product Profile.
  • Perform synthetic-molecule developability assessments and provide preclinical formulation support.
  • Perform biopharmaceutical assessments using predictive in-silico and in-vitro models to identify development strategies.
  • Provide early clinical support for synthetic liquid dosage forms, such as drug-in-bottle and parenteral forms, and technical transfers to support clinical manufacturing under good manufacturing practice requirements.
  • Develop, implement, and apply advanced solid-state nuclear magnetic resonance techniques to characterize the structures and interactions of small and large drug molecules, and investigate complex scientific questions in pharmaceutical materials science.
  • Explore and implement solid-state nuclear magnetic resonance techniques to improve the productivity, robustness, and efficiency of small-molecule and biologics development.
  • Develop and apply innovative solid-state nuclear magnetic resonance approaches to solve complex technical problems, including understanding excipient-drug interactions and quantitative analysis of heterogeneous mixtures.
  • Provide solid-state characterization support for biopharmaceutics assessment, form screening and selection, and drug-substance and drug-product process development for synthetic and biologics programs.
  • Interface with partners in Process Development and Research and Development.
  • Support departmental activities by training staff and presenting scientific results at internal and external meetings.
  • Build and maintain working relationships with internal and external stakeholders.
  • Contribute to regulatory filings, including investigational new drug and new drug application filings, assist in answering questions from regulatory authorities, and contribute to intellectual-property and patent filings.

About the Company

Amgen

Makes biotech medicines for serious illnesses

Amgen develops and makes biologic medicines, which are drugs built from proteins and antibodies grown in living cells, for serious conditions such as heart disease, cancer, and bone loss. Its anemia drug Epogen, approved in 1989, became one of the biotechnology industry's first blockbuster medicines. Amgen grows these drugs in large tanks called bioreactors, and its products include the cholesterol drug Repatha, the bone-building drug Evenity, and the severe asthma drug Tezspire. It earns money by selling these medicines, mostly through large drug wholesalers that supply hospitals and pharmacies. Amgen was founded in 1980 and is based in Thousand Oaks, California.

Company size
10,001+
Company stage
IPO
Headquarters
Thousand Oaks, CA
Founded
1980

Recently Posted Jobs

Explore more opportunities at Amgen

See more jobs